"Before receiving the implant, it was like having two black discs in my eyes, with the outside distorted," said Sheila Irvine ...

Having examined the options trading patterns of Illumina, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance Trading volume ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Geographic atrophy due to age-related macular degeneration (AMD) is the leading cause of irreversible blindness and affects more than 5 million persons worldwide. No therapies to restore vision in ...

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

China Medical University leads a multi-institution team reporting that MTAP deficiency suppresses cytosolic nucleic acid ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.